VIICTR
Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (4)
Nuclear factor-kappaB maintains TRAIL resistance in human pancreatic cancer cells.
Pancreatic acinar cells in culture: expression of acinar and ductal antigens in a growth-related manner.
Skeletal Muscle Mass Recovery Early After Left Ventricular Assist Device Implantation in Patients With Advanced Systolic Heart Failure.
Uncovering the Role of RNA-Binding Protein hnRNP K in B-Cell Lymphomas.
See All 4 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Nuclear factor-kappaB maintains TRAIL resistance in human pancreatic cancer cells.
Nuclear factor-kappaB maintains TRAIL resistance in human pancreatic cancer cells. Mol Cancer Ther. 2006 Sep; 5(9):2251-60.
View in:
PubMed
subject areas
Animals
Apoptosis
Boronic Acids
Bortezomib
Drug Synergism
Heterocyclic Compounds, 3-Ring
Humans
I-kappa B Proteins
Male
Mice
Mice, Inbred BALB C
Mice, Nude
NF-kappa B
NF-KappaB Inhibitor alpha
Pancreatic Neoplasms
Pyrazines
Pyridines
Receptors, TNF-Related Apoptosis-Inducing Ligand
Receptors, Tumor Necrosis Factor
Recombinant Proteins
RNA, Small Interfering
TNF-Related Apoptosis-Inducing Ligand
Xenograft Model Antitumor Assays
authors with profiles
CRAIG LOGSDON